The Asia-Pacific region had a COPD prevalence rate of 13.5% in 2019, exceeding the global average, with Mainland China showing the highest prevalence. This trend continues even today with the region showing a higher disease burden and deaths than the West.
Novotech Publishes Multi-Specific Monoclonal Antibodies Global Clinical Trial Landscape Report
Singapore - Novotech, the leading Asia Pacific centred biotech CRO has published
Read more